Last Posted: Sep 03, 2019
- Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes
MT Roe et al, Circulation, September 2, 2019 - New European Lipid Guidelines Take Aggressive Approach
S Hughes, Medscape, September 1, 2019 - Recovering From a Stroke Can Be a Long Road, But Don’t Give Up
CDC Information, 2019 - A gene-diet interaction-based score predicts response to dietary fat in the Women's Health Initiative
K Westerman et al, MedXRIV, August 2019 - Risk of Ischemic Stroke and Peripheral Arterial Disease in Heterozygous Familial Hypercholesterolemia: A Meta-Analysis.
Akioyamen Leo E et al. Angiology 2019 Sep 70(8) 726-736 - Cholesterol: Fact or Fiction?
Test your cholesterol smarts with this quiz. CDC, 2019 - Positive Topline Results from Phase 3 Trial of Evinacumab in Patients with Severe, Inherited Form of High Cholesterol
Regeneron, August 14, 2019 - Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction.
Lee Chongyou et al. Lipids in health and disease 2019 Apr 18(1) 95 - Incidence of Cardiovascular Disease in Patients with Familial Hypercholesterolemia Phenotype: Analysis of 5 Years Follow-Up of Real-World Data from More than 1.5 Million Patients.
Masana Luís et al. Journal of clinical medicine 2019 Jul 8(7) - Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia.
Trinder Mark et al. Journal of the American College of Cardiology 2019 Jul 74(4) 512-522
.png)
No hay comentarios:
Publicar un comentario